Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 589-596

  Chen, Xiao Li ^a   Zhou, Le ^a   Yang, Jun ^a   Shen, Fu Kun ^a   Zhao, Shi Ping ^a   Wang, Yi Li ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Microdissection; Pre cancerous lesion; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA ENOLASE; DJ 1 PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; MANGANESE SUPEROXIDE DISMUTASE; NUCLEOSIDE DIPHOSPHATE KINASE A; PEROXIREDOXIN 6; PHOSPHOGLYCERATE KINASE; PROHIBITIN; STRATIFIN; TRANSGELIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICRODISSECTION; MOLECULAR MECHANICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TISSUE SECTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 77956681960     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000302     Document Type: Article

References (23)

1. Stefaniuk P, Cianciara J and Wiercinska-Drapalo A: Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 16: 418-424, 2010.
2. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R and Bannasch P: Human hepatic preneoplasia: phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 431: 391-406, 1997.
3. Su Q, Zhang SX, Yang SJ, Liu J and Liu YF: Precancerous changes in hepatitis B and liver cirrhosis: a morphological and immunohistochemical study. J Fourth Milit Med Univ 16: 85-88, 1995.
4. Su Q: Precancerous lesion of human hepatocellular carcinoma. Chinese Journal of Diagnostic Pathology 10: 112-115, 2003.
5. Zhou L, Yang XF, Wang Y, Zhang YT, Geng YP, Si LS and Wang YL: Identification of metastasis-associated proteins of ovarian cancer by proteomics. Zhonghua Bing Li Xue Za Zhi 36: 814-818, 2007.
6. Bosch FX, Ribes J, Cléries R and Díaz M: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9: 191-211, 2005.
7. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
8. Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K and Hirohashi S: Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5: 1411-1422, 2005.
9. Cui JF, Liu YK, Pan BS, Song HY, Zhang Y, Sun RX, Chen J, Feng JT, Tang ZY, Yu YL, Shen HL and Yang PY: Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J Cancer Res Clin Oncol 130: 615-622, 2004.
10. Klade CS, Voss T and Krystek E: Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 1: 890-898, 2001.
11. Li LS, Kim H, Rhee H, Kim SH, Shin DH, Chung KY, Park KS, Paik YK, Chang J and Kim H: Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma. Proteomics 4: 3394-3400, 2004.
12. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS and Yom HC: The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 18: 505-509, 2003.
13. Shi YY, Wang HC, Yin YH, Sun WS, Li Y, Zhang CQ, Wang Y, Wang S and Chen WF: Identification and analysis of tumor-associated antigens in hepatocellular carcinoma. Br J Cancer 92: 929-934, 2005.
14. Lewis AG, Flanagan J, Marsh A, MP J and Mann G: Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer. Breast Cancer Res 7: R1005-R1016, 2005.
15. Urano T, Takahashi S, Suzuki T, Fujimura T, Fujita M, Kumagai J, Horie-Inoue K, Sasano H, Kitamura T, Ouchi Y and Inoue S: 14-3-3 sigma is down-regulated in human prostate cancer. Biochem Biophys Res Commun 319: 795-800, 2004.
16. Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM and Eble JN: Loss of 14-3-3 sigma in prostate cancer and its precursors. Clin Cancer Res 10: 3064-3068, 2004.
17. Sano T, Shimooka H, Weixa P, Segawa A, Jian Z, Motegi A, Nakayama H, Oyama T and Nakajima T: Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers. Pathol Int 54: 743-750, 2004.
18. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R and Iacobuzio-Donahue CA: Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev 15: 281-287, 2006.
19. Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ and Chow LP: Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J Proteome Res 4: 2062-2069, 2005.
20. St Clair DK and Oberley LW: Manganese superoxide dismutase expression in human cancer cells: a possible role of mRNA processing. Free Radic Res Commun 12-13 Pt 2: 771-778, 1991.
21. Kuang SY, Jackson PE, Wang JB, Lu PX, Muñoz A, Qian GS, Kensler TW and Groopman JD: Specific mutations of hepatitis B virus in plasma predict liver cancer development. PNAS 101: 3575-3580, 2004.
22. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M and Hirohashi S: Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37: 198-207, 2003.
23. Maguchi S: Tumor-associated impairment of the processing of hepatoma cathepsin D. Hokkaido Igaku Zasshi 63: 23-35, 1988.